Antimicrobial activity of phenolic acids against commensal, probiotic and pathogenic bacteria

Research in Microbiology

Volumn 161, Issue 5, 2010, Pages 372-382

  Cueva, Carolina ^a   Moreno Arribas, M Victoria ^a   Martín Álvarez, Pedro J ^a   Bills, Gerald ^b,c   Vicente, M Francisca ^b,c   Basilio, Angela ^b   Rivas, Concepción López ^b   Requena, Teresa ^d   Rodríguez, Juan M ^e   Bartolomé, Begoña ^a  

^a INSTITUTO DE FERMENTACIONES INDUSTRIALES CSIC   (Spain)

^b Medical affairs Merck sharp and Dohme ltd   (Spain)

^c Fundacion MEDINA   (Spain)

^d INSTITUTO DEL FRÍO CSIC   (Spain)

^e UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Antimicrobial activity; Escherichia coli; Pathogens; Phenolic acids; Probiotics

Indexed keywords

3 HYDROXYBENZOIC ACID; 3 HYDROXYPHENYLACETIC ACID; 3 HYDROXYPHENYLPROPIONIC ACID; 3,4 DIHYDROXYPHENYLACETIC ACID; 4 HYDROXYBENZOIC ACID; 4 HYDROXYPHENYLACETIC ACID; BENZOIC ACID; CATECHIN; DIHYDROCAFFEIC ACID; EPICATECHIN; MYCOPHENOLIC ACID; PHENYLACETIC ACID; PHENYLPROPIONIC ACID DERIVATIVE; PHLORETIC ACID; PROTOCATECHUIC ACID; UNCLASSIFIED DRUG; VANILLIC ACID;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CANDIDA ALBICANS; DRUG STRUCTURE; ESCHERICHIA COLI; LACTOBACILLUS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BENZOIC ACIDS; CANDIDA ALBICANS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, FUNGAL; ESCHERICHIA COLI; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; HYDROXYBENZOIC ACIDS; INTESTINES; LACTOBACILLUS; PHENYLACETATES; PHENYLPROPIONATES; PROBIOTICS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP;

CANDIDA ALBICANS; ESCHERICHIA COLI; LACTOBACILLUS; LACTOBACILLUS BREVIS; LACTOBACILLUS CORYNIFORMIS; LACTOBACILLUS FERMENTUM; LACTOBACILLUS PARAPLANTARUM; LACTOBACILLUS PLANTARUM; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 77954316093     PISSN: 09232508     EISSN: 17697123     Source Type: Journal    
DOI: 10.1016/j.resmic.2010.04.006     Document Type: Article

References (39)

1. Aura A.-M. Microbial metabolism of dietary phenolic compounds. Phytochem. Rev. 2008, 7:407-429.
2. Bills G.F., Platas G., Overy D.P., Collado J., Fillola A., Jimenez M.R., Martin J., del Val A.G., et al. Discovery of the parnafungins, antifungal metabolites that inhibit mRNA polyadenylation, from the Fusarium larvarum complex and other Hypocrealean fungi. Mycologia 2009, 101:445-468.
3. Blaut M., Clavel T. Metabolic diversity of the intestinal microbiota: implications for health and disease. J. Nutr. 2007, 137:751S-755S.
4. Clifford M.N. Diet-derived phenols in plasma and tissues and their implication for health. Planta. Med. 2004, 70:1103-1114.
5. Chaffin W.L. Candida albicans cell wall proteins. Microbiol. Mol. Biol. Rev. 2008, 72:495-544.
6. Choi S.H., Gu M.B. Phenolic toxicity - detection and classification through the use of a recombinant bioluminescent Escherichia coli. Environ. Toxicol. Chem. 2001, 20:248-255.
7. Cukrowska B., Lodínová-Žádníková R., Enders C., Sonnenborn U., Schulze J., Tlaskalova-Hogenova H. Specific proliferative and antibody responses of premature infants to intestinal colonization with non-pathogenic probiotic E. coli strain Nissle 1917. Scand. J. Immunol. 2002, 55:204-209.
8. Gao K., Xu A., Krul C., Venema K., Liu Y., Niu Y.T., Lu J.X., Bensoussan L., Seeram N.P., Heber D., Henning S.M. Of the major phenolic acids formed during human microbial fermentation of tea, citrus, and soy flavonoid supplements, only 3,4-dihydroxyphenylacetic acid has antiproliferative activity. J. Nutr. 2006, 136:52-57.
9. Gonthier M.-P., Cheynier V., Donovan J.L., Manach C., Morand C., Mila I., Lapierre C., Remesy C., Scalbert A. Microbial aromatic metabolites formed in the gut account for a major fraction of the polyphenols excreted in urine of rats fed red wine polyphenols. J. Nutr. 2003, 133:461-467.
10. Holloway B.W., Krishnapillai V., Morgan A.F. Chromosomal genetics of Pseudomonas. Microbiol. Rev. 1979, 43:73-102.
11. Ikigai H., Nakae T., Hara Y., Shimamura T. Bactericidal catechins damage the lipid bilayer. Biochim. Biophys. Acta. 1993, 1147:132-136.
12. Jenner A.M., Rafter J., Halliwell B. Human fecal water content of phenolics: the extent of colonic exposure to aromatic compounds more options. Free Radic. Biol. Med. 2005, 38:763-772.
13. Jiménez E., Fernández L., Maldonado A., Martín R., Olivares M., Xaus J., Rodríguez J.M. Oral administration of lactobacilli strains isolated from breast milk as an alternative for the treatment of infectious mastitis during lactation. Appl. Envir. Microb. 2008, 74:4650-4655.
14. Juvent B.J., Kanner J., Schved F., Weisslowicz H. Factors that interact with the antibacterial action of thyme essential oil and its active constituents. J. Appl. Bacteriol. 1994, 76:626-631.
15. Kodali S., Galgoci A., Young K., Painter R., Silver L.L., Herath K.B., Singh S.B., Cully D., Barrett J.F., Schmatz D., Wang J. Determination of selectivity and efficacy of fatty acid synthesis inhibitors. J. Biol. Chem. 2005, 280:1669-1677.
16. Köhler T., Epp S.F., Curty L.K., Pechère J.-C. Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa. J. Bacteriol. 1999, 181:6300-6305.
17. Koronakis V., Sharff A., Koronakis E., Luisi B., Hughes C. Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature 2000, 405:914-919.
18. Lara-Villoslada F., Sierra S., Martín R., Delgado S., Rodríguez J.M., Olivares M., Xaus J. Safety assessment of two probiotic strains, Lactobacillus coryniformis CECT 5711 and Lactobacillus gasseri CECT 5714. J. Appl. Microbiol. 2007, 103:175-184.
19. Lee H.C., Jenner A.M., Low C.S., Lee Y.K. Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res. Microbiol. 2006, 157:876-884.
20. Lebeer S., Vanderleyden J., De Keersmaecker S.C. Genes and molecules of lactobacilli supporting probiotic action. Microbiol. Mol. Biol. Rev. 2008, 72:728-764.
21. Martín R., Langa S., Reviriego C., Jiménez E., Marín M.L., Xaus J., Fernández L., Rodríguez J.M. Human milk is a source of lactic acid bacteria for the infant gut. J. Pediatr. 2003, 143:754-758.
22. Martín R., Olivares M., Marín M.L., Fernández L., Xaus J., Rodríguez J.M. Probiotic potential of 3 lactobacilli strains isolated from breast milk. J. Hum. Lact. 2005, 21:8-17.
23. Martín R., Olivares M., Marín M.L., Xaus J., Fernández L., Rodríguez J.M. Characterization of a reuterin-producing Lactobacillus coryniformis strain isolated from a goat's milk cheese. Int. J. Food Microbiol. 2005, 104:267-277.
24. Novick R.P. Molecular Biology of the Staphylococci 1990, VCH, New York, 1-40.
25. Nurmi T., Mursu J., Heinonen M., Nurmi A., Hiltunen R., Voutilainen S. Metabolism of berry anthocyanins to phenolic acids in humans. J. Agric. Food Chem. 2009, 57:2274-2281.
26. Papadopoulou C., Soulti K., Roussis I.G. Potential antimicrobial activity of red and white wine phenolic extracts against strains of Staphylococcus aureus, Escherichia coli and Candida albicans. Food Technol. Biotechnol. 2005, 43:41-46.
27. Peláez, P., Vicente, P., Genilloud, O., Bills, G., Tormo, J.R., González, A., De La Cruz, M., Martín J, et al., 2008. A strategy for antibiotic discovery based on microbial natural products using empiric whole cell primary screens coupled with a dereplication genome-wide platform using antisense strains. Gordon Research Conference on New Antibacterial Discovery & Development, Lucca, Italy.
28. Perry C.C., Weatherly M., Beale T., Randriamahefa A. Atomic force microscopy study of the antimicrobial activity of aqueous garlic versus ampicillin against Escherichia coli and Staphylococcus aureus. J. Sci. Food. Agric. 2009, 89:958-964.
29. Rechner A.R., Kroner C. Anthocyanins and colonic metabolites of dietary polyphenols inhibit platelet function. Thromb. Res. 2005, 116:327-334.
30. Roemer T., Jiang B., Davison J., Ketela T., Veillette K., Breton A., Tandia F., Linteau A., et al. Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery. Mol. Microbiol. 2003, 50:167-181.
31. Scalbert A., Williamson G. Dietary intake and bioavailability of polyphenols. J. Nutr. 2000, 130:2073S-2085S.
32. Si W., Gong J., Tsao R., Zhou T., Yu H., Poppe C., Johnson R., Du Z. Antimicrobial activity of essential oils and structurally related synthetic food additives towards selected pathogenic and beneficial gut bacteria. J. Appl. Microbiol. 2006, 100:296-305.
33. Stevenson D.E., Hurst R.D. Polyphenolic phytochemicals - just antioxidant or much more?. Cell Mol. Life Sci. 2007, 64:2900-2916.
34. Taguri T., Tanaka T., Kouno I. Antibacterial spectrum of plant polyphenols and extracts depending upon hydroxyphenyl structure. Biol. Pharm. Bull. 2006, 29:2226-2235.
35. Tamura N., Murakami S., Oyama Y., IshiguroYamaguchi A. Direct interaction of multidrug efflux transporter AcrB and outer membrane channel tolC detected via site-directed disulfide cross-linking. Biochemistry 2005, 44:11115-11121.
36. Tzounis X., Vulevic J., Kuhnle G.G.C., George T., Leonczak J., Gibson G.R., Kwik-Uribe C., Spencer J.P.E. Flavonol monomer-induced changes to the human fecal microflora. Br. J. Nutr. 2008, 99:782-792.
37. Vattem D.A., Lin Y.T., Ghaedian R., Shetty K. Cranberry synergies for dietary management of Helicobacter pylori infections. Process. Biochem. 2005, 40:1583-1592.
38. Vicente F., Basilio A., Platas G., Collado J., Bills G.F., Del Val A.G., Martin J., Tormo J.R., et al. Distribution of the antifungal agents sordarins across filamentous fungi. Mycol. Res. 2009, 113:754-770.
39. Young K., Silver L.L., Bramhill D., Cameron P., Eveland S.S., Raetz C.R., Hyland S.A., Anderson M.S. The envA permeability/cell division gene of Escherichia coli encodes the second enzyme of lipid A biosynthesis. UDP-3-O-(R-3-hydroxymyristoyl).N-acetylglucosamine deacetylase. J. Biol. Chem. 1995, 270:30384-30391.